Streetbeat News

Stock Prices

ABM

ABM Industries shares rose following the release of Q3 financial results that exceeded expectations. The company also increased its FY24 adjusted EPS guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:21 pm

ORCL

Oracle Corporation (NYSE:ORCL) is set to release its Q1 FY2025 earnings on Sept. 9, with expected earnings of $1.33 per share and revenue of $13.24 billion. The company offers a 1.12% annual dividend yield, translating to $0.40 per share quarterly. To earn $500 monthly from dividends, an investment of approximately $534,788 is needed.

Portfolio Pulse from Avi Kapoor

September 06, 2024 | 12:19 pm

BABA

BIDU

NVDA

Nvidia AI chips are being smuggled into China, allowing smaller cloud providers to offer competitive rates despite U.S. sanctions. This highlights ongoing Chinese investment in AI and the impact of export controls on companies like Alibaba and Nvidia.

Portfolio Pulse from Anusuya Lahiri

September 06, 2024 | 12:18 pm

BE

Bloom Energy's stock is experiencing a decline following a downgrade by Jefferies from Buy to Hold, with a reduced price target from $15 to $11.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:17 pm

BAC

FN

HOOD

MSFT

The article discusses recent insider sales of shares by executives at Fabrinet, Bank of America, Microsoft, and Robinhood. Insider sales can indicate concerns about a company's prospects or that the stock is overpriced. Notable sales include Warren Buffett selling Bank of America shares and Satya Nadella selling Microsoft shares.

Portfolio Pulse from Avi Kapoor

September 06, 2024 | 12:17 pm

AVGO

PL

SWBI

Smith & Wesson Brands, Planet Labs, and Broadcom are among the stocks moving lower in Friday's pre-market session. Smith & Wesson reported a larger-than-expected loss, while Broadcom, despite better-than-expected results, also saw a decline.

Portfolio Pulse from Avi Kapoor

September 06, 2024 | 12:12 pm

DOOO

BRP shares declined following the release of disappointing Q2 sales results.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:08 pm

CLF

X

US Steel shares rose as Cleveland-Cliffs expressed interest in acquiring and investing in assets that US Steel may shut down.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:04 pm

VTYX

Ventyx Biosciences has initiated a Phase 2a trial for its drug VTX3232, targeting early Parkinson's Disease, with the first patient dosed. This marks a significant step in the company's drug development pipeline.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:03 pm

LE

Lands' End (NASDAQ:LE) has been analyzed by 7 analysts, all of whom are bullish. The average 12-month price target is $18.71, up 2.3% from the previous target. Despite positive analyst sentiment, Lands' End faces financial challenges, including declining revenue and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 12:01 pm